Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Rosko

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Geriatric Oncology|June 3, 2020
Multidisciplinary telemedicine and the importance of being seenSarah A Wall, Brittany Knauss, Amy Compston, et al.
Journal of the American College of Radiology : JACR|August 8, 2024
Practical Insights From Integrating Financial Hardship Screening at a Comprehensive Cancer CenterSamilia Obeng-Gyasi, Yevgeniya Gokun, Carolyn J Presley, et al.
Journal of Geriatric Oncology|January 27, 2026
Systematic review of frailty, functional status & comorbidities in older adults with multiple myeloma undergoing high dose therapy & autologous stem cell transplantNadine Abdallah, Ashlyn O'Leary, Cynthia M Schmidt, et al.
Blood Cancer Journal|November 10, 2023
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myelomaMichael Ozga, Qiuhong Zhao, Laila Huric, et al.
Journal of Clinical Medicine|November 14, 2020
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020Srinivas Devarakonda, Francesca Cottini, Naresh Bumma, et al.
BMC Cancer|October 6, 2025
AI-driven chemotoxicity prediction in colorectal cancer: impact of race, SDOH, and biological agingClaire Han, Christin Burd, Jesse Plascak, et al.
Leukemia|January 26, 2020
Simplified frailty assessment tools: are we really capturing frailty or something else?Smith Giri, Grant Williams, Ashley Rosko, et al.
Haematologica|July 13, 2023
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myelomaAbdullah M Khan, Kiatlyn Dvorak, Qiuhong Zhao, et al.
Haematologica|June 12, 2025
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern eraMegan Broughton, Subodh Bhatta, Doshi Sonali, et al.
Cancers|August 14, 2025
Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15)Yvonne Efebera, Vera Suman, Shira Dinner, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Geriatric Oncology|June 3, 2020
Multidisciplinary telemedicine and the importance of being seenSarah A Wall, Brittany Knauss, Amy Compston, et al.
Journal of the American College of Radiology : JACR|August 8, 2024
Practical Insights From Integrating Financial Hardship Screening at a Comprehensive Cancer CenterSamilia Obeng-Gyasi, Yevgeniya Gokun, Carolyn J Presley, et al.
Journal of Geriatric Oncology|January 27, 2026
Systematic review of frailty, functional status & comorbidities in older adults with multiple myeloma undergoing high dose therapy & autologous stem cell transplantNadine Abdallah, Ashlyn O'Leary, Cynthia M Schmidt, et al.
Blood Cancer Journal|November 10, 2023
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myelomaMichael Ozga, Qiuhong Zhao, Laila Huric, et al.
Journal of Clinical Medicine|November 14, 2020
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020Srinivas Devarakonda, Francesca Cottini, Naresh Bumma, et al.
BMC Cancer|October 6, 2025
AI-driven chemotoxicity prediction in colorectal cancer: impact of race, SDOH, and biological agingClaire Han, Christin Burd, Jesse Plascak, et al.
Leukemia|January 26, 2020
Simplified frailty assessment tools: are we really capturing frailty or something else?Smith Giri, Grant Williams, Ashley Rosko, et al.
Haematologica|July 13, 2023
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myelomaAbdullah M Khan, Kiatlyn Dvorak, Qiuhong Zhao, et al.
Haematologica|June 12, 2025
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern eraMegan Broughton, Subodh Bhatta, Doshi Sonali, et al.
Cancers|August 14, 2025
Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15)Yvonne Efebera, Vera Suman, Shira Dinner, et al.
Pageof 6